List view / Grid view
20 January 2011 | By Eli Lilly and Company
The U.S. FDA Peripheral and Central Nervous System Drugs Advisory Committee decided today that it could not recommend approval of Amyvid™ (florbetapir) at this time...
19 January 2011 | By Merck KGaA
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUSa study...
18 January 2011 | By National Institute for Health Research
A new report shows collaboration between the life sciences industry, the NHS and the National Institute for Health Research (NIHR) Clinical Research Network...
18 January 2011 | By GlaxoSmithKline (GSK)
GSK expects to record a legal charge for the fourth quarter of 2010 of £2.2 billion ($3.4 billion)...
17 January 2011 | By Roche
Erich Hunziker, Chief Financial Officer, Chief Information Officer and Deputy Head of the Corporate Executive Committee has decided to retire from Roche at the end of March 2011...
17 January 2011 | By Andrew Lloyd & Associates
Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease...
17 January 2011 | By The Scott Partnership
Expansion enables them to handle larger projects from preformulation through to Phase IIa...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr Eric Gluck will host a scientific presentation highlighting the benefits of the Thermo Scientific B.R.A.H.M.S procalcitonin (PCT) assay at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
13 January 2011 | By KDM Communications
Scientists at the Center for CIPSM, have taken advantage of the 3D scanning capabilities of the premium Quad4 Monochromators™-based Infinite M1000 microplate reader...
12 January 2011 | By Eli Lilly and Company
Eli Lilly announces that the FDA Gastrointestinal Drugs Advisory Committee has recommended that additional studies be conducted...
11 January 2011 | By The Scott Partnership
Prism Ideas, announced that the company has appointed Carol Hills as chief operations officer (COO) following a successful two-year period as the company's director of medical marketing...
11 January 2011 | By Eli Lilly and Company
Global agreement will lead to joint development of diabetes compounds currently in mid- and late-stage development...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it will showcase its clinical assay for Procalcitonin (PCT), which aids in the risk assessment of critically ill patients with sepsis, at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
7 January 2011 | By Lallemand Pharma Europe
Lallemand Pharma Europe and GlaxoSmithKline announced the launch of ISMIGEN® in Poland...
6 January 2011 | By The Scott Partnership
Novozymes Biopharma is presenting two scientific posters on the manufacturing and use of recombinant albumin in formulation...
